Bergeson

Bergeson & Campbell, P.C. is a law firm located in Washington, D.C. Employing 37 individuals, the firm generates annual revenue of $7.6 million. Bergeson & Campbell specializes in legal matters related to chemical product regulation and approval. Their areas of expertise include TSCA, FIFRA/FQPA, FDA medical device and product approval, registration, and data compensation arbitrations, as well as chemical product litigation. The firm provides counsel and representation to a diverse clientele, encompassing individuals, businesses, trade associations, and industry coalitions operating in sectors such as chemicals, biotechnology, pharmaceuticals, and manufacturing. The firm boasts an AV rating, signifying the highest ranking for legal ability and ethical standards. Their team conducts advocacy before various government agencies, including EPA, FDA, HHS, OSHA, ATSDR, NTP, OMB, and state regulatory bodies. Bergeson & Campbell actively contributes to their clients' business strategies by providing comprehensive compliance planning, toxic tort defense, and guidance on acquisitions. For inquiries and consultations, please visit their website at lawbc.com.